Randomized study compares PIEB and CEI for third trimester medical termination analgesia

Third trimester medical termination of pregnancy necessitates effective and humane analgesia. Historically, Continuous Epidural Infusion (CEI) has been a standard method for pain management during labor and similar procedures. However, recent advancements in obstetric analgesia have highlighted the potential superiority of Programmed Intermittent Epidural Bolus (PIEB). Studies in routine labor epidural analgesia have demonstrated that PIEB can improve pain control, reduce local anesthetic consumption, and enhance patient satisfaction compared to CEI. Despite these promising findings, the specific application and comparative effectiveness of PIEB versus CEI for analgesia during third trimester voluntary termination of pregnancy remains an unaddressed clinical question. This gap prevents the optimization of pain management protocols for patients undergoing this sensitive procedure, underscoring the need for direct comparative research.

This randomized controlled study was designed to directly compare two established epidural analgesia techniques for patients undergoing third trimester medical termination of pregnancy. Participants were prospectively randomized into one of two treatment arms: receiving either Programmed Intermittent Epidural Bolus (PIEB) or Continuous Epidural Infusion (CEI). The primary objective was to assess patient satisfaction with the assigned analgesia method, with the central hypothesis being that PIEB administration would lead to a significantly higher degree of patient satisfaction compared to CEI. The study aimed to provide robust evidence regarding the optimal epidural technique for pain management in this specific clinical population.